Profusa, Inc. (PFSA) News
Follow Profusa, Inc. (PFSA) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 32 public stories across 17 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Profusa receives ISO 13485:2016 certificate from GMED
Profusa received an ISO 13485:2016 certificate from GMED.
EQUITY | Oct 15, 2026, 10:30 AM UTC
L
Profusa Raises $700,000 Through Convertible Note Financing
Profusa issued a senior secured convertible promissory note to Ascent Partners Fund with $769,230.77 in principal and 7% interest. The note matures as early as Oct. 15, 2027, or upon an option closing, and is convertible
EQUITY | Oct 15, 2026, 10:13 AM UTC
H
Why FingerMotion Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Shares of FingerMotion Inc (NASDAQ: FNGR ) rose sharply in pre-market trading after the company announced it had entered into a definitive Share Purchase Agreement to acquire 100% of Newbit Technology Inc. Under the agre
LIVE | Sep 30, 2026, 09:32 AM UTC
L
Profusa, Inc. (PFSA) Gets Positive ISO 13485 Decision; Advances MDR Path for Lumee
Profusa said GMED issued a positive decision on its ISO 13485 quality certification and that it continues MDR conformity assessments for the Lumee Oxygen Platform toward potential CE marking. Timing and outcome of remain
NEWS | Sep 24, 2026, 11:33 AM UTC
L
Profusa Announces Significant Progress Towards Lumee® Oxygen Platform CE Mark with ISO 13485 Certification Expected in Early October
BERKELEY, CA, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. NASDAQ:PFSA, a digital health company pioneering next-generation biosensor technologies today announced that the Company has received a positive decision fro
NEWS | Sep 24, 2026, 11:32 AM UTC
L
PFSA - Profusa Announces Significant Progress Towards Lumee® Oxygen Platform CE Mark with ISO 13485 Certification Expected in Early October
PFSA - Profusa Announces Significant Progress Towards Lumee® Oxygen Platform CE Mark with ISO 13485 Certification Expected in Early October
NEWS | Sep 24, 2026, 11:30 AM UTC
M
Profusa raises $350,000 via senior secured 7% convertible note
Profusa issued a senior secured convertible note to Ascent Partners Fund for $350,000 in proceeds (face value $384,615.38). The note pays 7% cash interest, matures as early as Sep 16, 2027, and is convertible at $4.28 pe
EQUITY | Sep 16, 2026, 10:13 AM UTC
L
Profusa clears Nasdaq compliance issues
Content provided by Seeking Alpha is intended for information purposes only, and that Seeking Alpha does not offer any personalist investment advice and is not a licensed securities dealer, broker, US investment adviser
NEWS | Sep 15, 2026, 11:22 AM UTC
L
Profusa cleared Nasdaq bid-price and equity rules, placed on one-year mandatory monitor
Profusa demonstrated compliance with Nasdaq bid-price and equity listing rules and remains subject to a one-year mandatory Panel Monitor.Key Highlights:Original SEC Filing: Profusa, Inc. [ PFSA ] - 8-K - Sep. 15, 2026Thi
REGULATION | Sep 15, 2026, 10:13 AM UTC
L
Profusa Receives Nasdaq Compliance Determination
Profusa Receives Nasdaq Compliance Determination
NEWS | Sep 15, 2026, 10:01 AM UTC
L
PFSA - Profusa, Inc. Receives Nasdaq Compliance Determination
PFSA - Profusa, Inc. Receives Nasdaq Compliance Determination
NEWS | Sep 15, 2026, 10:00 AM UTC
M
Profusa issues $329,670 senior secured convertible note; $300,000 proceeds
Profusa entered a financing agreement issuing a senior secured convertible promissory note to Ascent Partners Fund for $329,670.33 principal, generating $300,000 proceeds via original issue discount. The note carries 7%
EQUITY | Sep 01, 2026, 12:24 PM UTC
L
Profusa (PFSA) reports Q2 2026 financial results; updates G3 Vision deal conditions
Profusa (PFSA) announces Q2 2026 financial results and provides progress on the option agreement conditions to close with G3 Vision Labs.
EARNINGS | Aug 20, 2026, 12:32 PM UTC
H
Home Depot earnings top estimates as Nasdaq drops 1.25%
Home Depot (NYSE: HD) reports second-quarter earnings of $4.92 per share and sales of $47.861 billion, both above analyst consensus, while the Nasdaq falls 1.25%.
EARNINGS | Aug 18, 2026, 01:59 PM UTC
M
XOS jumps after securing U.S. Air Force contract
XOS rises 120% after securing a U.S. Air Force contract, while the feed also flags PFSA, WETO, SGLY, TRUG, BIAF, SXTC and EJH as small-cap upside movers.
MNA | Aug 18, 2026, 12:20 PM UTC
L
PFSA and YYAI announce reverse stock splits for Aug 17
PFSA will conduct a 1-for-4 reverse stock split and YYAI will conduct a 1-for-20 reverse stock split on Monday, Aug 17, per TradeXchange.
EQUITY | Aug 17, 2026, 09:06 AM UTC
L
PFSA and YYAI announce Aug 17 reverse stock splits
PFSA will execute a 1-for-4 reverse split on Monday Aug 17, while YYAI will execute a 1-for-20 reverse split on the same date, per TradeXchange Newsdesk.
REGULATION | Aug 16, 2026, 12:02 PM UTC
L
Profusa (PFSA) announces 1-for-4 reverse stock split
Profusa (PFSA) announces a 1-for-4 reverse stock split.
REGULATION | Aug 13, 2026, 11:01 AM UTC
H
Profusa Signs Option For G3 Vision Labs Acquisition
Profusa to acquire diagnostics company
MNA | Jul 31, 2026, 09:15 PM UTC
L
Top Small Cap Negative News Movers Premarket: STAK: -54% Momentum Mover OMH: -40% Pricing of $4 Million Registered Direct Offering WETO: -35
Top Small Cap Negative News Movers Premarket: STAK: -54% Momentum Mover OMH: -40% Pricing of $4 Million Registered Direct Offering WETO: -35% to Enter into Warehouse Robotics Cooperation Agreement OFAL: -25% 1-for-10 Con
EQUITY | Jul 27, 2026, 12:16 PM UTC
H
Why Is Profusa Stock Falling Monday?
Profusa Inc. (NASDAQ: PFSA ) stock fell in Monday premarket trading after the company announced leadership changes and signed a non-binding acquisition term sheet. PFSA has lost about 99.95% of its value over the past 12
RATES | Jul 27, 2026, 11:46 AM UTC
H
Profusa To Merge With Privately Held, Commercial-Stage Health Diagnostics And Toxicology Testing Company; Profusa To Issue 19.99% Stake to T
Following the contemplated transaction, the combined company is expected to operate as a public diagnostics company with national CLIA-certified laboratories, recurring revenues from a diversified base of providers servi
RATES | Jul 27, 2026, 10:05 AM UTC
L
PFSA - Profusa Announces Key Management Changes and Signing of Non-Binding Term Sheet for the Acquisition of a Commercial Stage Diagnostics
PFSA - Profusa Announces Key Management Changes and Signing of Non-Binding Term Sheet for the Acquisition of a Commercial Stage Diagnostics Company
EQUITY | Jul 27, 2026, 10:00 AM UTC
L
Profusa shares are trading lower after the company announced a 1-for-25 reverse stock split.
Profusa shares are trading lower after the company announced a 1-for-25 reverse stock split.
EQUITY | Jul 02, 2026, 03:12 PM UTC
L
Profuse Announces 1-For-25 Reverse Stock Split, Effective July 7
Profusa, Inc. ("Profusa" or the "Company") (NASDAQ: PFSA ), a commercial stage digital health company pioneering a next-generation technology platform enabling the continuous monitoring of an individual’s biochemistry, t
EQUITY | Jul 02, 2026, 03:03 PM UTC
L
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Curis (NASDAQ: CRIS ) stock rose 9.0% to $0.46 during Wednesday's after-market session. The company's market cap stands at $20.3 million. Humacyte (NASDAQ: HUMA ) shares moved upwards by 5.45% to $0.71. The marke
EQUITY | Jul 01, 2026, 09:05 PM UTC
H
Small Caps Fall
Several small cap stocks are experiencing significant declines premarket due to various news announcements.
EQUITY | Jun 24, 2026, 01:13 PM UTC
H
Small Caps Fall
Several small cap stocks are experiencing significant declines premarket due to various reasons including reverse splits, momentum moves, and new offerings.
EQUITY | Jun 24, 2026, 12:21 PM UTC
M
12 Health Care Stocks Move
Twelve health care stocks are moving in Wednesday's pre-market session, with Pulsenmore and Catheter Precision leading the gainers and Nuwellis and Mobile-health Network leading the losers
EQUITY | Jun 24, 2026, 12:09 PM UTC
H
PFSA Acquires PanOmics
Profusa shareholders approve acquisition of PanOmics multi-omics diagnostics platform and reverse stock split
EQUITY | Jun 24, 2026, 12:07 PM UTC
M
PFSA Approves Strategic Initiatives
Profusa shareholders approve strategic initiatives at 2026 annual meeting, supporting PanOmics acquisition and balance sheet strengthening
EARNINGS | Jun 24, 2026, 12:01 PM UTC
M
PFSA Approves Stock Split
Profusa shareholders approve amendment for common stock split at ratio of 1-to-5 to 1-for-200 over next two years
EQUITY | Jun 23, 2026, 05:16 PM UTC